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ABSTRACT
Objectives: The aim of the study is to determine the impact of the experimental diabetes and the chronic hypoxia on 
pregnancy development and rat fetal body weight.
Material and methods: The experiment was performed on female Wistar rats. Animals were divided into the experimen-
tal groups. I — Controls, II — Untreated diabetes, III — Insulin-treated diabetes, IV — No diabetes with chronic hypoxia, 
V — Untreated diabetes and chronic hypoxia, VI — Insulin- treated diabetes and chronic hypoxia. Diabetes was induced in 
groups II, III, V and VI with intraperitoneal injection of streptozocin (STZ) at a dose of 40 mg/kg. Chronic hypoxia was induced 
by placing dams (groups IV, V and VI) in conditions of 10.5% oxygen and 89.5%. Insulin was administered subcutaneously 
at the dose of 9 IU/kg. Starting from the 6th day after STZ injection and chronic hypoxia conditions animals were caged 
together for 12 hours for 3 consecutive days to ensure fertilization. On day 21 of gestation the animals were decapitated, 
the fetuses were removed and weighted.
Results: Mean fetal body weight in separate groups were: I — 5.38 g, II — 6.04g, III — 5.32g, IV— 5.56 g, V — 3.45 g, VI — 6.23 g.
Conclusions: Pre-existing type 1 diabetes  does not affect fetal body weight compared to healthy newborn control rats. Pro-
longed hypoxia does not impact on fetal body weight. Chronic hypoxia during pregnancy complicated with untreated type 
1 diabetes mellitus leads to significant reduction of fetal body weight. Insulin treatment reversed the detrimental effect of 
chronic hypoxia on fetal development.
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INTRODUCTION
Diabetes is a multifactorial disease. It causes several 
maternal and fetal vascular anomalies and may lead to the 
impaired uteroplacental blood flow resulting with fetal hy-
poxia. Gestational diabetes has been confirmed to cause 
the intrauterine growth restriction. It is connected with 
an elevated incidence of congenital diseases and may lead 
to postpartum neurological disorders. Mild and moderate 
intellectual deficiencies are reported in offspring of diabetic 
mothers as well as mothers suffering from asthma, renal 
disorders or epilepsy. It appears that the severity of these 
disorders is correlated with a degree of glycemic control 
during pregnancy. An inadequate metabolic balance in 
pregnant women with diabetes seems to account for worse 
results in intelligence (IQ) tests in offspring at school age. 
Metabolic disorders during the first and third trimester of 
gestation seem to be most prognosticly relevant [1]. Chil-
dren born to mothers with well-controlled diabetes score 
similarly in intelligence tests to children born to healthy 
mothers. Their motor functions, ability of attention can be, 
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however, adversely affected, which may result in psychomo-
tor hyperactivity [2]. The relationship between ketonemia 
in mothers with gestational diabetes and lower IQ score in 
offspring has been extensively described in literature [1]. The 
age of  pregnant diabetic mothers is also a relevant factor, 
a negative correlation has been demonstrated between 
maternal age and offspring IQ scores. This association has 
not been observed in women with normal carbohydrate 
metabolism [3–5]. Studies in animal models of gestatio-
nal diabetes in rats and their offspring have demonstrated 
a reduced level of neurotransmitters such as taurine and 
γ-amino-butyric acid (GABA), both critical for normal brain 
development and L-carnosine production, known for its 
neuroprotective function. This is unlikely to have no reper-
cussions on the structural and functional development of 
central nervous system (CNS) [6]. Fetal CNS is most probably 
impaired during cell differentiation as a result of  hyper-
glycemia- induced oxidative stress during gestation [7]. In 
experimental models of diabetes, a substantial decrease 
in the activity of endogenous antioxidant enzymes with 
significantly lower levels of vitamin C and E in fetal cells has 
been observed, which may be one of the potential factors 
responsible for CNS abnormalities. Therefore, vitamin C, E, 
carotenoids and folic acid supplementation may have a posi-
tive effect on anti-oxidative protective functions by reducing 
the defects caused by metabolic disorders in diabetes [8].
Hypoxia induced by gestational diabetes affects fetal 
CNS development and is connected with an altered se-
xual behavior both reproductive and non-reproductive in 
future. Likewise children exposed prenatally to hypoxia 
may suffer from abnormalities such as suction dysfunction, 
mother-infant bonding disorders, attention deficit disor-
ders, motor deficits, encephalopathy and cerebral palsy. 
Hypoxia leads to neurochemical and structural brain injury 
at the cellular level, disrupting the maintenance of brain 
homeostasis. Extensive and severe damages of the brain 
may occur during neural transformation, differentiation, 
migration, synapse and nerve fibre formation. Moreover, 
during the development of receptors, hypoxia influence 
on the elevated level of endogenous monoamines, opioid 
peptides and excitatory aminoacids, inhibiting normal fetal 
brain development. Hypoxia is potentially  accountable for 
the onset of autism and autoagressive behavior in children 
and could also be a causative factor in adulthood for Alzhe-
imer’s disease, may have a detrimental effect on the quality 
of life and social situation of the affected individuals [9, 10]. 
OBJECTIVES
The aim of the study is to determine the impact of the 
experimental diabetes and the coexistent hypoxia on pre-
gnancy development and rat fetal body weight.
MATERIAL AND METHODS
The experiment was carried out on female Wistar 
rats. The animals were obtained from laboratory animal 
facility (Laboratory animals cultivation, Lipiec Zbigniew, 
Brwinów, Poland). The animals were on average 120 days 
old and their body weight ranged from 200 to 250 g. For 
experimental purposes, the female rats were selected and 
randomly allocated to groups, each comprising 6 dams. Male 
Wistar rats weighing 240–260 g were used for fertilization. 
There were two times less males than females (2:1 ratio). The 
animals were housed in standard laboratorial conditions, 
under 12 hour day/night cycle, with an access to food and 
water ad libitum and in strictly controlled temperature 23oC 
and air humidity (45–50%). The controls were housed in the 
same container under the same temperature and humidity 
conditions. Experimental procedures have been approved 
by the Local Ethical Committee in Lublin and have been in 
agreement with European Communities Council Directive 
on the use of animals in experimental studies.
Experimental diabetes was induced with streptozocin 
(STZ) (Sigma-Aldrich, St. Louis, USA). Diabetes in animals was 
treated with NPH insulin and Gensulin N (Bioton, Poland). 
All other reagents were obtained from POCH (Gliwice, Po-
land). The analyzed substances were diluted directly prior to 
administration in a sterile solution 0.9% NaCl and injected 
intraperitoneally to experimental groups. Controls were 
injected intraperitoneally with the same volume of 0.9% 
NaCl solution in a proportion to kilogram of body weight. 
Animals were divided into the following experimental 
groups. Ultimately, on the day of decapitation, each group 
consisted of 8 dams. 
• I — Controls;
• II — Group with untreated diabetes; 
• III — Group with insulin-treated diabetes;
• IV — Group without diabetes with chronic hypoxia;
• V — Group with untreated diabetes and chronic hypoxia;
• VI — Group with insulin treated diabetes and chronic 
hypoxia.
Diabetes was induced in groups II, III, V and VI with 
a single intraperitoneal injection of streptozocin dissolved 
in 0.05M citrate buffer, pH = 4.2 at a dose of 40 mg/kg body 
weight in 5 mL of volume. The presence of glucosuria was 
established with a semiquantitive method with Ketodiastix 
(Bayer) test straps 7 days after injection and it confirmed the 
diagnosis of diabetes. Control group (I and IV) was treated 
with 0.05 M citrate buffer of pH 4.2 without STZ. Diabetes 
was diagnosed in 85% of treated female rats.
Insulin treatment of diabetic rats was provided to gro-
ups III and VI 7 days after STZ injection and was continued 
until the end of experiment. NPH insulin was administered 
subcutaneously at the dose of 9 IU/kg body weight. The 
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group with untreated diabetes received 0.9% NaCl injection 
instead of insulin. The control group, which previously had 
been treated only with citrate buffer without STZ, was tre-
ated with injections of 0.9% NaCl. Injections were performed 
every day at the same time, with 24 hour intervals between 
injections. The treatment was conducted over 22 days.  
Prior to insulin administration, dams from all groups 
were weighed, on daily basis, to determine the proper dose 
of insulin based on the stage of pregnancy and the current 
weight of the pregnant dam.  
Starting from the 6th day after streptozotocin injection, 
the experimental females and males were caged together 
(2 females per 1 male) for 12 hours for 3 consecutive days 
to ensure fertilization. Conception was confirmed on the 
12th day after the last coitus.
Chronic hypoxia was induced by placing pregnant rat 
dams (groups IV, V and VI) in a gas mixture consist of 10.5% 
oxygen and 89.5% nitrogen 24 hours a day from 15 to 20 day 
of gestation. Animals were provided with food and water 
ad libidum during hypoxic exposure.
On day 21 of gestation (29 days after STZ injection) the 
animals were decapitated. Immediately after pregnant dams 
were decapitated, the fetuses were removed, decapitated, 
their sex determined and tissues were taken for further 
analysis. 
The statistical analysis
The obtained experimental data was statistically ana-
lyzed. The default margin of error probability of 5% was 
used and the threshold for statistical significance was set at 
p < 0.05. The study results were presented graphically in the 
Table 1 and Figure 1. All statistical analyses were performed 
using Statistica 5.0 Software. 
RESULTS
The obtained results indicate that, pre-existing type 
1 diabetes mellitus, whether insulin-treated or untreated, 
does not affect fetal body weight compared to healthy 
newborn control rats. Similarly, prolonged hypoxia did not 
impact fetal body weight. However, chronic hypoxia during 
pregnancy complicated with untreated type 1 diabetes 
mellitus leads to significant reduction of fetal body weight, 
affecting 65% of control group (Fig.1). Insulin treatment 
reversed the detrimental effect of chronic hypoxia on fetus 
development.
DISCUSSION
Intrauterine growth restriction (IUGR) is defined as a con-
dition in which the  estimated weight of the fetus is below the 
10th percentile for the gestational age and whose abdominal 
circumference is below the 2.5th percentile or birth weight 
is below 2500 g [11]. It has been proved that either genetic, 
placental or maternal factors may lead to IUGR. Diabetes 
mellitus and intrauterine hypoxia are well-known causative 
factors. IUGR may have lasting consequences on postnatal 
growth and development; in some instances the develop-
ment of metabolic syndrome can be attributed to IUGR [12].
Gestational hypoxia may occur in different conditions 
and may trigger disorders affecting  not only fetus deve-
lopment but also its future life. Fetal hypoxia may develop 
in course of multiple pathologies. Placental insufficiency, 
pulmonary diseases (e.g. asthma, chronic obstructive pul-
monary disease), smoking, maternal anemia, chronic mater-
nal diseases may lead to fetal decreased oxygen supply and 
the development of IUGR [12].  In the model of rat chronic 
intermittent hypoxia, an asymmetrical growth restriction of 
newborn rats was reported. Moreover, increased body fat 
Table 1. Fetal body weights — males and females in the experimental groups
Group Mean fetal weight [g] Standard deviation (SD)
Controls — CTR 5.38 1.09
Untreated diabetes — II 6.04 0.45
Insulin-treated diabetes — III 5.32 0.81
Chronic hypoxia — IV 5.56 1.22
Untreated diabetes and chronic hypoxia — V 3.45 1.07
Insulin treated diabetes and chronic hypoxia — IV 6.23 0.70
10
5
0
CTR II III VIV VI
[g
]
*** p < 0.05
***
a
***
***
***
Figure 1. Fetal body weights in each experimental group
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deposition, hyperglycemia and hyperinsulinemia occurred 
during adolescence [13].
Nowadays, diabetes in pregnant women is widespread. 
It is estimated that pre-gestational diabetes complicates 
about 4% and gestational diabetes affects even 8% of pre-
gnancies [14]. Depending on the type of diabetes, different 
complications may be expected. Untreated or uncontrolled 
diabetes type 1 results inter alia in ketoacidosis and hyper-
glycemia. The risk of spontaneous miscarriage, congenital 
malformations, stillbirth, fetal growth restriction, fetal ma-
crosomia, preeclampsia, early mortality or preterm delivery 
is increased [15, 16]. Pre-gestational diabetes affects also 
placental weight and function, causing placental circulatory 
disorders, vasculopathy and placental insufficiency [17]. 
Gestational diabetes may create conditions likely to induce 
inflammation and placental hypoxia [18].
Diabetic placentas may present histological changes 
similar to placentas from large-for-gestational-age infants 
[19]. Placental structural dysfunctions are dependent on the 
duration of diabetes and can lead to chronic fetal hypoxia 
[20].  Pregnancy planning for patients with type 1 diabetes 
reduces the risk of adverse pregnancy outcomes [21]. Proper 
metabolic control both before and during pregnancy is cru-
cial to reduce the risk of complication. It is known that proper 
glycemic control results in normal fetal weight. Moderately 
increased values of glycated hemoglobin are related with 
macrosomia and very high glycated hemoglobin values are 
related with IUGR [22]. However, in some clinical studies, 
despite the increased risk of fetal abnormalities, perinatal 
complications and perinatal morbidity, there was no direct 
correlation between some of those factors and glycated 
hemoglobin [15, 23]. In vitro studies have shown that the 
growth-retarding and teratogenic effect of even lower do-
ses of glucose and ketone bodies acting simultaneously, is 
greater than when each substance acted separately [24]. 
In the course of uncontrolled type 1 diabetes mellitus both 
hyperglycemia and elevated ketone bodies occur. In our 
experiment, untreated diabetic rats exhibited an extremely 
high glucose level and presence of ketone bodies. Treat-
ment with insulin reversed those anomalies. Surprisingly, 
pre-gestational diabetes mellitus type 1 did not affect fetal 
body weight and we did not observe significant differen-
ces between fetuses from insulin treated and untreated 
females. However, coexistence of untreated type 1 diabetes 
and chronic hypoxia during pregnancy lead to significant 
reduction of fetal weight. Those results may suggest that 
the combination of harmful factors exert stronger effect 
than each factor acting separately. The insignificant changes 
in fetal body weight in the group of untreated diabetic rats 
may be due to the short duration of diabetes and lack of 
late complications. Insulin treatment reduced glucose and 
ketone bodies level to virtually normal, and reversed the 
detrimental effects of type 1 diabetes. In treated animals 
hypoxia was not a sufficient factor to disturb fetal growth.
CONCLUSIONS
The obtained data suggests that disturbances of rat 
fetal growth is dependent on combinations of harmful fac-
tors which escalate their own effects on fetal development. 
Optimal treatment of each irregularity during pregnancy 
decreases the risk of their overlap. 
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